Tumor Tracking Systems Market: Global Industry Analysis and Forecast (2023-2029)


Tumor Tracking Systems Market size is expected to grow at a CAGR of 10.21% during the forecast period and the market size is expected to reach nearly US$ 5.89 Bn. by 2029.

Tumor Tracking Systems Market Overview:

Tumor tracking systems are used to track the tumor in patient body. It is important for radiation therapy to deliver sufficient radiation dose without damaging the surrounding healthy tissue. Localization of tumor becomes difficult due to patient’s position shift, change of tumor area during series of treatment, and tumor movement due to respiration. Tumor Tracking Systems make imaging and radiotherapy more precise and safer for patients.Tumor Tracking Systems Market To Know About The Research Methodology :- Request Free Sample Report

Tumor Tracking Systems Market Dynamics:


Rising prevalence of tumor cancer and technological advancements drive the market growth.

Cancer is one of the leading causes of death globally. The disease witnessed significant growth in the last few decades, and it is expected to grow rapidly over the forecast period. Use of technologically advanced devices like Calypso, which provides real-time tumor tracking with benefits such as no requirement of ionization radiation during localization of tumor. These devices help surgeons to perform treatment with minimal complications. Increasing research and development activities to find the cure for various cancer types and locate the tumor precisely further expected to drive the growth of the tumor tracking systems market.

The report has profiled fifteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed.

Tumor Tracking Systems Market Segment Analysis:


The tumor tracking systems market is segmented on the basis of device type, application and end-user.

Based on Application, Prostate Cancer segment dominates the market as it is the second-highest form of cancer affecting men worldwide. As per the American Cancer Society, in 2018, the United States witnessed around 164,690 new cases of prostate cancer, causing over 26,430 deaths. About 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. Due to such a high prevalence of prostate cancer, demand for tumor tracking is expected to rise during the forecast years.

Tumor Tracking Systems Market Regional Insights:


North America dominates the Tumor Tracking Systems Market.

The prevalence of prostate and breast cancer in the region is the major driving factor for the market growth. Increasing investments from the government in the use of biomarkers in drug discovery, detection of specific tumors and genetic studies for the identification of cancer propels the market growth in the region. Also, high awareness, availability of reimbursement policies, and high cost of the products in the U.S. propel the tumor tracking systems market in North America.

The report also helps in understanding Global Tumor Tracking Systems Market dynamics, structure by analyzing the market segments and projects the Global Tumor Tracking Systems Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Tumor Tracking Systems Market make the report investor’s guide.

Tumor Tracking Systems Market scope: Inquire before buying






Tumor Tracking Systems Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2017 to 2022
Market Size in 2022:
US $ 2.98 Bn.




Forecast Period 2023 to 2029 CAGR:
10.21%
Market Size in 2029:
US $ 5.89 Bn.




 Segments Covered:
by Device Type
• Direct Tumor Tracking Systems
• Respiratory Tracking Systems




by Application
• Prostate Cancer
• Lung Cancer
• Breast Cancer
• Others




by End-Users
• Hospitals
• Cancer Research Institutes
• Ambulatory Surgical Centers
• Others






Tumor Tracking Systems Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Tumor Tracking Systems Market Key Players:

• Varian Medical Systems, Inc.
• Accuray Incorporated
• Brainla
• Elekta AB
• Thermo Fisher Scientific
• Miltenyi Biotec
• Cell Biolabs, Inc.
• STEMCELL Technologies Inc.
• QIAGEN
• Genekam
• Menarini Silicon Biosystems, Inc.
• Koninklijke Philips N.V.
• CureMD Healthcare
• RaySearch Laboratories AB
• MICA Information Systems, Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Tumor Tracking Systems Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Tumor Tracking Systems Market?
Ans: The Global Tumor Tracking Systems Market is growing at a CAGR of 10.21% during forecasting period 2023-2029.

3. What is scope of the Global Tumor Tracking Systems Market report?
Ans: Global Tumor Tracking Systems Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Tumor Tracking Systems Market?
Ans: The important key players in the Global Tumor Tracking Systems Market are – Varian Medical Systems, Inc., Accuray Incorporated, Brainla, Elekta AB, Thermo Fisher Scientific, Miltenyi Biotec, Cell Biolabs, Inc., STEMCELL Technologies Inc., QIAGEN, Genekam, Menarini Silicon Biosystems, Inc., Koninklijke Philips N.V., CureMD Healthcare, RaySearch Laboratories AB, MICA Information Systems, Inc.

5. What is the study period of this Market?
Ans: The Global Tumor Tracking Systems Market is studied from 2022 to 2029. 




1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Tumor Tracking Systems Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2022
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Tumor Tracking Systems Market
3.4. Geographical Snapshot of the Tumor Tracking Systems Market, By Manufacturer share
4. Global Tumor Tracking Systems Market Overview, 2022-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Tumor Tracking Systems Market
5. Supply Side and Demand Side Indicators
6. Global Tumor Tracking Systems Market Analysis and Forecast, 2022-2029
6.1. Global Tumor Tracking Systems Market Size & Y-o-Y Growth Analysis.
7. Global Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
7.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
7.1.1. Direct Tumor Tracking Systems
7.1.2. Respiratory Tracking Systems
7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
7.2.1. Injectable
7.2.2. Oral
7.2.3. Capsules/Tablets
7.2.4. Syrup
7.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
7.3.1. Hospitals
7.3.2. Cancer Research Institutes
7.3.3. Ambulatory Surgical Centers
7.3.4. Others
8. Global Tumor Tracking Systems Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
9.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
9.1.1. Direct Tumor Tracking Systems
9.1.2. Respiratory Tracking Systems
9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
9.2.1 Prostate Cancer
9.2.2 Lung Cancer
9.2.3 Breast Cancer
9.2.4 Others
9.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
9.3.1. Hospitals
9.3.2. Cancer Research Institutes
9.3.3. Ambulatory Surgical Centers
9.3.4. Others
10. North America Tumor Tracking Systems Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
11.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
11.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
12. Canada Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
12.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
12.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
13. Mexico Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
13.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
13.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
14. Europe Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
14.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
14.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
15. Europe Tumor Tracking Systems Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
16.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
16.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
17. France Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
17.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
17.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
18. Germany Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
18.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
18.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
19. Italy Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
19.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
19.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
20. Spain Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
20.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
20.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
21. Sweden Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
21.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
21.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
22. CIS Countries Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
22.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
22.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
23. Rest of Europe Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
23.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
23.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
24. Asia Pacific Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
24.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
24.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
25. Asia Pacific Tumor Tracking Systems Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
26.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
26.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
27. India Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
27.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
27.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
28. Japan Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
28.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
28.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
29. South Korea Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
29.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
29.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
30. Australia Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
30.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
30.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
31. ASEAN Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
31.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
31.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
32. Rest of Asia Pacific Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
32.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
32.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
33. Middle East Africa Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
33.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
33.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
34. Middle East Africa Tumor Tracking Systems Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
35.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
35.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
36. GCC Countries Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
36.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
36.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
37. Egypt Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
37.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
37.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
38. Nigeria Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
38.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
38.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
39. Rest of ME&A Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
39.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
39.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
40. South America Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
40.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
40.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
41. South America Tumor Tracking Systems Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
42.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
42.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
43. Argentina Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
43.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
43.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
44. Rest of South America Tumor Tracking Systems Market Analysis and Forecasts, 2022-2029
44.1. Market Size (Value) Estimates & Forecast By Device Type, 2022-2029
44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029
44.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Tumor Tracking Systems Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
45.3. Company Profile : Key Players
45.3.1. Varian Medical Systems, Inc.
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Product Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. Accuray Incorporated
45.3.3. Brainla
45.3.4. Elekta AB
45.3.5. Thermo Fisher Scientific
45.3.6. Miltenyi Biotec
45.3.7. Cell Biolabs, Inc.
45.3.8. STEMCELL Technologies Inc.
45.3.9. QIAGEN
45.3.10. Genekam
45.3.11. Menarini Silicon Biosystems, Inc.
45.3.12. Koninklijke Philips N.V.
45.3.13. CureMD Healthcare
45.3.14. RaySearch Laboratories AB
45.3.15. MICA Information Systems, Inc.
46. Primary Key Insights
  • INQUIRE BEFORE BUYING